Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study - The Lancet Oncology

SARS-CoV-2 DNA vaccine tested in animal model

COVID-19 in patients with hematologic malignancy - ScienceDirect

Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines

Cancer in the Midst of COVID-19, A Report

Immunogenicity of two doses of BNT162b2 and mRNA‐1273 vaccines for solid cancer patients on treatment with or without a previous SARS‐CoV‐2 infection - La Verde - 2023 - International Journal of Cancer

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis

Frontiers Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents

Vaccines, Free Full-Text

Biomedicines, Free Full-Text